Duaklir Pressair Powder, Metered
Product Images NDC 70515-001

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Duaklir Pressair (NDC 70515-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Covis Pharma Us, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aclidinium_bromide_structural_formula (Aclidinium Bromide Structural Formula)

Chemical structure showing the molecular arrangement of aclidinium bromide, the active ingredient in DUAKLIR PRESSAIR inhalation powder.*

FDA Label Image

Figure_1 (Figure 1)

A line graph showing changes from baseline in FEV1 (mL) LS means over 24 hours following administration of aclidinium bromide, formoterol fumarate 400/12 mcg combination, aclidinium bromide 400 mcg, and formoterol fumarate 12 mcg. The x-axis represents time in hours, and the y-axis shows change in FEV1. An arrow indicates evening administration at 12 hours.*

FDA Label Image

Figure_2 (Figure 2)

A line graph illustrating the change from baseline in FEV1 (mL) over 24 hours comparing aclidinium bromide/formoterol fumarate 400/12 mcg, aclidinium bromide 400 mcg, and formoterol fumarate 12 mcg. The x-axis represents time in hours with a marker indicating evening administration at 12 hours, and the y-axis shows the change in FEV1. The graph shows patterns of lung function change following dosing.*

FDA Label Image

Formoterol_fumarate_structural_formula (Formoterol Fumarate Structural Formula)

Chemical structure diagram showing the molecular formula of the active ingredients aclidinium bromide and formoterol fumarate in DUAKLIR PRESSAIR inhalation powder.*

FDA Label Image

Figure_a (Image 01)

An instructional diagram of the DUAKLIR PRESSAIR inhaler showing key parts labeled: protective cap, control window with green (ready to use) and red (correctly inhaled) indicators, dose indicator, orange button, and mouthpiece. The image highlights operational features of this powder metered respiratory inhalation device.*

FDA Label Image

Figure_b (Image 02)

An instructional illustration showing hands holding an inhaler device for DUAKLIR PRESSAIR powder, metered for respiratory inhalation. The image demonstrates the action of squeezing and pulling the orange part of the device, indicated by an arrow and labeled 'Squeeze here and pull.'*

FDA Label Image

Figure_c (Image 03)

Illustration of the DUAKLIR PRESSAIR inhaler showing the top view with a digital dose counter displaying the number 60, a red indicator area, and the mouthpiece opening labeled for user awareness.*

FDA Label Image

Figure_d (Image 04)

An instructional illustration showing a hand holding the DUAKLIR PRESSAIR inhaler device. The inhaler is white with an orange button or lever, used for delivering the metered powder medication by respiratory inhalation.*

FDA Label Image

Figure_e (Image 05)

An instructional illustration labeled Figure E showing a hand holding the DUAKLIR PRESSAIR inhaler device in a position for use. The diagram highlights correct finger placement on the inhaler to facilitate inhalation of the powdered medication.*

FDA Label Image

Figure_f (Image 06)

An instructional illustration showing a hand holding a white DUAKLIR PRESSAIR inhaler with an orange button. An upward arrow indicates pressing or releasing the inhaler for use.*

FDA Label Image

Figure_g (Image 07)

A diagram labeled Figure G showing a close-up view of the top portion of a Duaklir Pressair inhaler. The image highlights a green indicator and a numeric dose counter displaying the number 60, illustrating the inhaler's dose count and readiness.*

FDA Label Image

Figure_h (Image 08)

An instructional illustration showing the top view of an inhaler mouthpiece with a dose counter displaying the number 60. A red X overlays the image, indicating that this step or condition is not recommended or incorrect usage for the DUAKLIR PRESSAIR inhaler.*

FDA Label Image

Figure_i (Image 09)

An instructional illustration showing a side profile of a person's lower face demonstrating exhalation by blowing air forward, indicated by a green arrow extending from the mouth. This image likely relates to proper technique for using an inhalation device.*

FDA Label Image

Figure_j (Image 10)

Illustration showing the proper use of the DUAKLIR PRESSAIR inhaler, with a person exhaling through the device's mouthpiece. The label indicates it as Figure J, demonstrating the respiratory inhalation technique for the powder metered dosage form.*

FDA Label Image

Figure_k (Image 11)

An instructional illustration labeled Figure K showing the mouthpiece end of a DUAKLIR PRESSAIR inhaler device. The image highlights a red indicator and a dose counter displaying '60', indicating the inhaler's dose status.*

FDA Label Image

Figure_l (Image 12)

An instructional illustration labeled Figure L showing the top view of a dry powder inhaler device with a dose counter displaying the number 60. The image features a red X mark over it, indicating an action not to be done or an incorrect state of the device.*

FDA Label Image

Figure_m (Image 13)

Instructional illustration showing hands holding the DUAKLIR PRESSAIR inhaler. The image demonstrates pressing the orange button at the top of the inhaler, indicated by an arrow, likely as part of the activation or dose preparation process.*

FDA Label Image

Figure_n (Image 14)

Instructional diagram showing the dose indicator window on a DUAKLIR PRESSAIR inhaler, illustrating how the dose indicator moves slowly from 60 to 0, marked at intervals of 60, 50, 40, 30, 20, 10, and 0 with a red band appearing near zero dose level.*

FDA Label Image

Figure_o (Image 15)

An illustration showing the top view of a device with a numeric dose counter display indicating the number 0. Below the display is a green button or indicator. The image is labeled as Figure O, suggesting it is part of an instructional or product use diagram, likely related to the DUAKLIR PRESSAIR inhalation device.*

FDA Label Image

Figure_p (Image 16)

Illustration showing a side view of a DUAKLIR PRESSAIR inhaler device in the locked position. The device is white with a small orange section visible and is designed for respiratory powder metered dosage delivery.*

FDA Label Image

60 Metered Doses Carton (Image 17)

Packaging label for Duaklir Pressair inhalation powder, containing aclidinium bromide and formoterol fumarate. The label shows the strength as 400 mcg/12 mcg per actuation and indicates it contains 60 metered doses. The dosage form is powder for oral inhalation. The labeler is Covis Pharma US, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.